Literature DB >> 23864234

No evidence of a link between multiple sclerosis and the vaccine against the human papillomavirus.

Paolo Pellegrino1, Carla Carnovale, Valentina Perrone, Stefania Antoniazzi, Marco Pozzi, Emilio Clementi, Sonia Radice.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23864234     DOI： 10.1007/s10654-013-9830-y

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


× No keyword cloud information.
  5 in total

1.  Demyelinating disease and polyvalent human papilloma virus vaccination.

Authors:  Jason Chang; Denise Campagnolo; Timothy L Vollmer; Roberto Bomprezzi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-10-09       Impact factor: 10.154

2.  CNS demyelination and quadrivalent HPV vaccination.

Authors:  I Sutton; R Lahoria; Il Tan; P Clouston; Mh Barnett
Journal:  Mult Scler       Date:  2008-09-19       Impact factor: 6.312

3.  Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance.

Authors:  Michael S Gold; Peter McIntyre
Journal:  Sex Health       Date:  2010-09       Impact factor: 2.706

4.  Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions.

Authors:  Claire-Anne Siegrist; Edwin M Lewis; Juhani Eskola; Stephen J W Evans; Steven B Black
Journal:  Pediatr Infect Dis J       Date:  2007-11       Impact factor: 2.129

5.  Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine.

Authors:  Barbara A Slade; Laura Leidel; Claudia Vellozzi; Emily Jane Woo; Wei Hua; Andrea Sutherland; Hector S Izurieta; Robert Ball; Nancy Miller; M Miles Braun; Lauri E Markowitz; John Iskander
Journal:  JAMA       Date:  2009-08-19       Impact factor: 56.272
  5 in total
  5 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

2.  The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Reporting Systems.

Authors:  Paolo Pellegrino; Valentina Perrone; Marco Pozzi; Carla Carnovale; Cristiana Perrotta; Emilio Clementi; Sonia Radice
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

Review 3.  The role of Toll-like receptor 4 polymorphisms in vaccine immune response.

Authors:  P Pellegrino; F S Falvella; S Cheli; C Perrotta; E Clementi; S Radice
Journal:  Pharmacogenomics J       Date:  2015-03-31       Impact factor: 3.550

Review 4.  Safety of Human Papillomavirus Vaccines: An Updated Review.

Authors:  Anastasia Phillips; Cyra Patel; Alexis Pillsbury; Julia Brotherton; Kristine Macartney
Journal:  Drug Saf       Date:  2018-04       Impact factor: 5.606

Review 5.  Vaccines and multiple sclerosis: a systematic review.

Authors:  Mia Topsøe Mailand; Jette Lautrup Frederiksen
Journal:  J Neurol       Date:  2016-09-07       Impact factor: 6.682
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.